MedTrace Logo

Myopia Control Efficacy of Second-generation DIMS Spectacle Lenses on Fast Progressing Myopes

NCT05888792 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2026-04-22

No results posted yet for this study

Summary

The purpose of this study is to examine the efficacy and performance of the variant of Defocus Incorporated Spectacle lenses on controlling myopia progression in fast progressing myopic children.

Conditions

  • Myopia

Interventions

OTHER

Variant of Defocus Incorporated Spectacle lens (DG2)

DG2 is a variant of Defocus Incorporated Spectacle lens that corrects the distance refraction and provides myopic defocus simultaneously

Sponsors & Collaborators

  • HOYA Lens Thailand LTD.

    collaborator INDUSTRY

  • The Hong Kong Polytechnic University

    lead OTHER

Principal Investigators

  • Dennis Yan Yin Tse, PhD · School of Optometry, The Hong Kong Polytechnic University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
4 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-29
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05888792 on ClinicalTrials.gov